Published in Drug Week, June 2nd, 2000
The company has rights to proven technology and a prototype system from its majority shareholder, Quantech, Ltd. (QQQQ) that will enable it to commercialize its Flex CHIP Kinetic Analysis System in 2001.
"HTS Biosystems intends to be the definitive source of high-throughput instrument systems and chemistries in the fields of functional genomics, proteomics, and drug discovery," said Gregory Freitag, HTS. "FLEX CHIP will...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week